Bartlett NL - Search Results

1

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.

Wildes TM, Farrington L, Yeung C, Harrington AM, Foyil KV, Liu J, Kreisel F, Bartlett NL, Fenske TS. Wildes TM, et al. Among authors: bartlett nl. Ther Adv Hematol. 2014 Feb;5(1):3-12. doi: 10.1177/2040620713514682. Ther Adv Hematol. 2014. PMID: 24490019 Free PMC article. Review.

2

Drug development for recurrent and refractory classical Hodgkin lymphoma.

Wildes TM, Bartlett NL. Wildes TM, et al. Among authors: bartlett nl. Leuk Lymphoma. 2009 Apr;50(4):529-40. doi: 10.1080/10428190902756586. Leuk Lymphoma. 2009. PMID: 19373650 Review.

3

Anti-CD30 Antibodies for Hodgkin lymphoma.

Foyil KV, Bartlett NL. Foyil KV, et al. Among authors: bartlett nl. Curr Hematol Malig Rep. 2010 Jul;5(3):140-7. doi: 10.1007/s11899-010-0053-y. Curr Hematol Malig Rep. 2010. PMID: 20446121 Review.

4

Brentuximab vedotin for the treatment of CD30+ lymphomas.

Foyil KV, Bartlett NL. Foyil KV, et al. Among authors: bartlett nl. Immunotherapy. 2011 Apr;3(4):475-85. doi: 10.2217/imt.11.15. Immunotherapy. 2011. PMID: 21463188 Review.

5

Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.

Foyil KV, Kennedy DA, Grove LE, Bartlett NL, Cashen AF. Foyil KV, et al. Among authors: bartlett nl. Leuk Lymphoma. 2012 Mar;53(3):506-7. doi: 10.3109/10428194.2011.614706. Epub 2011 Oct 10. Leuk Lymphoma. 2012. PMID: 21867368 No abstract available.

6

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.

Fehniger TA, Larson S, Trinkaus K, Siegel MJ, Cashen AF, Blum KA, Fenske TS, Hurd DD, Goy A, Schneider SE, Keppel CR, Wagner-Johnston ND, Carson KR, Bartlett NL. Fehniger TA, et al. Among authors: bartlett nl. Blood. 2011 Nov 10;118(19):5119-25. doi: 10.1182/blood-2011-07-362475. Epub 2011 Sep 21. Blood. 2011. PMID: 21937701 Free PMC article. Clinical Trial.

7

Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma.

Carson KR, Bartlett NL, McDonald JR, Luo S, Zeringue A, Liu J, Fu Q, Chang SH, Colditz GA. Carson KR, et al. Among authors: bartlett nl. J Clin Oncol. 2012 Sep 10;30(26):3217-22. doi: 10.1200/JCO.2011.39.2100. Epub 2012 May 29. J Clin Oncol. 2012. PMID: 22649138 Free PMC article.

8

Solid, low-attenuation splenic lesions on computed tomography in patients with indolent lymphoma often signal transformation: a series of ten patients.

Welch JS, Foyil KV, Powers ML, Middleton WD, Bartlett NL. Welch JS, et al. Among authors: bartlett nl. Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):452-4. doi: 10.1016/j.clml.2012.08.001. Epub 2012 Sep 14. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22981965 No abstract available.

9

Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.

Foyil KV, Bartlett NL. Foyil KV, et al. Among authors: bartlett nl. Cancer J. 2012 Sep-Oct;18(5):450-6. doi: 10.1097/PPO.0b013e31826aef4a. Cancer J. 2012. PMID: 23006951 Review.

10

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

Dehdashti F, Laforest R, Gao F, Shoghi KI, Aft RL, Nussenbaum B, Kreisel FH, Bartlett NL, Cashen A, Wagner-Johnston N, Mach RH. Dehdashti F, et al. Among authors: bartlett nl. J Nucl Med. 2013 Mar;54(3):350-7. doi: 10.2967/jnumed.112.111948. Epub 2013 Jan 28. J Nucl Med. 2013. PMID: 23359657 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters